Subtle Medical Awarded Phase II Funding for SBIR Grant to Expand SubtleSYNTH™ Technology to Brain Imaging

The news comes on the heels of SubtleSYNTH receiving FDA clearance of SubtleSYNTH™ for Spine STIRs MENLO PARK, Calif., Sept. 4, 2024 /PRNewswire/ — Subtle Medical, a leader in AI-powered medical imaging solutions, is proud to announce that it has been awarded Phase II funding of its NIH…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.